X-ray and molecular modelling in fragment-based design of three small quinoline scaffolds for HIV integrase inhibitors

被引:16
作者
Majerz-Maniecka, Katarzyna [1 ]
Musiol, Robert [2 ]
Skorska-Stania, Agnieszka [1 ]
Tabak, Dominik [2 ]
Mazur, Pawel [2 ]
Oleksyn, Barbara J. [1 ]
Polanski, Jaroslaw [2 ]
机构
[1] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland
[2] Univ Silesia, Inst Chem, PL-40007 Katowice, Poland
关键词
HIV integrase; Quinolines; Fragment-based drug design; Crystal structure; BIOLOGICAL-ACTIVITY SPECTRUM; BINDING MODE; DRUG DESIGN; STREPTONIGRIN; LAVENDAMYCIN; STYRYLQUINOLINES; REPLICATION; MECHANISM; CRYSTAL; LESSONS;
D O I
10.1016/j.bmc.2011.01.045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Crystal structures of three small molecular scaffolds based on quinoline, 2-methylquinoline-5,8-dione, 5-hydroxy-quinaldine-6-carboxylic acid and 8-hydroxy-quinaldine-7-carboxylic acid, were characterised. 5-Hydroxy-quinaldine-6-carboxylic acid was co-crystallized with cobalt(II) chloride to form a model of divalent metal cation-ligand interactions for potential HIV integrase inhibitors. Molecular docking into active site of HIV IN was also performed on 1WKN PDB file. Selected ligand-protein interactions have been found specific for active compounds. Studied structures can be used as scaffolds in fragment-based design of new potent drugs. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1606 / 1612
页数:7
相关论文
共 41 条
[1]  
ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P27
[2]  
[Anonymous], 2006, ANALOGUE BASED DRUG
[3]  
[Anonymous], 2006, CHAPTER 3PRIVILEGED
[4]   Highly efficient and practical syntheses of lavendamycin methyl ester and related novel quinolindiones [J].
Behforouz, M ;
Haddad, J ;
Cai, W ;
Arnold, MB ;
Mohammadi, F ;
Sousa, AC ;
Horn, MA .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (19) :6552-6555
[5]   STREPTONIGRIN AND LAVENDAMYCIN PARTIAL STRUCTURES - PROBES FOR THE MINIMUM, POTENT PHARMACOPHORE OF STREPTONIGRIN, LAVENDAMYCIN, AND SYNTHETIC QUINOLINE-5,8-DIONES [J].
BOGER, DL ;
YASUDA, M ;
MITSCHER, LA ;
DRAKE, SD ;
KITOS, PA ;
THOMPSON, SC .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (10) :1918-1928
[6]   Styrylquinolines, integrase inhibitors acting prior to integration:: a new mechanism of action for anti-integrase agents [J].
Bonnenfant, S ;
Thomas, CM ;
Vita, C ;
Subra, F ;
Deprez, E ;
Zouhiri, F ;
Desmaële, D ;
d'Angelo, J ;
Mouscadet, JF ;
Leh, H .
JOURNAL OF VIROLOGY, 2004, 78 (11) :5728-5736
[7]  
Burgi H.-B., 1994, STRUCTURE CORRELATIO
[8]  
*CCG INC, 200810 MOE CCG INC
[9]   Integrase illuminated [J].
Cherepanov, Peter .
EMBO REPORTS, 2010, 11 (05) :328-328
[10]   Crystal and electronic structures of magnesium(II), copper(II), and mixed magnesium(II)-copper(II) complexes of the quinoline half of styrylquinoline-type HIV-1 integrase inhibitors [J].
Courcot, B. ;
Firley, D. ;
Fraisse, B. ;
Becker, P. ;
Gillet, J.-M. ;
Pattison, P. ;
Chernyshov, D. ;
Sghaier, M. ;
Zouhiri, F. ;
Desmaele, D. ;
d'Angelo, J. ;
Bonhomme, F. ;
Geiger, S. ;
Ghermani, N. E. .
JOURNAL OF PHYSICAL CHEMISTRY B, 2007, 111 (21) :6042-6050